← Back to Patent Explorer
US5541296A Expired / Lapsed US ⏱️ 0.0 years remaining

Monocyte adhesion protein and monoclonal antibody thereto

Assignee: Albert Einstein College of Medicine
•
Filing: 1994-12-16
•
Granted: 1996-07-30
•
Expires: 2014-12-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to a method for the prevention of monocyte adherence to the endothelial cells lining blood vessels, their subsequent invasion of surrounding tissues and diseases related thereto. It comprises inducing a monocyte adhesion protein to the surface of endothelial cells by treatment with specific cytokines, preparing a monoclonal antibody to the monocyte adhesion protein and contacting the antibody to the protein to form a complex. The monoclonal antibody does not bind to the cell surface proteins VCAM or ELAM. The complex results in a decrease in the adherence of monocytes to endothelial cells and thereby attenuates or prevents the harmful effects of monocyte invasion of endothelial cells and surrounding tissues.

Inventors

  • 👤 Joan W. Berman
  • 👤 Tina M. Calderon

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 22:49
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 39 words
A monoclonal antibody which binds to the same monocyte adhesion protein located on the surface of endothelial cells as monoclonal antibody secreted by hybridoma 11023 deposited with the American Type Culture Collection, which protein is not VCAM or ELAM.
Claim 2
Dependent Claim 39 words
A monoclonal antibody which binds to the same monocyte adhesion protein located on the surface of endothelial cells as monoclonal antibody secreted by hybridoma 11023 deposited with the American Type Culture Collection, which protein is not VCAM or ELAM.
Claim 3
Dependent Claim 6 words
Hybridoma cell line ATCC No. HB11023.
Claim 4
Dependent Claim 6 words
Hybridoma cell line ATCC No. HB11023.
Claim 5
Dependent Claim 11 words
Monoclonal antibody produced by the hybridoma cell line of claim 2.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-07-30 2000-01-29 2000-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-07-30 2004-01-29 2004-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-07-30 2008-01-29 2008-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag